Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients

Failure to recognize the presence of competing risk or to account for it may result in misleading conclusions. We aimed to perform a competing risk analysis to assess the efficacy of the low molecular weight heparin dalteparin versus unfractionated heparin (UFH) in venous thromboembolism (VTE) in me...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guowei, Cook, Deborah J., Levine, Mitchell A.H., Guyatt, Gordon, Crowther, Mark, Heels-Ansdell, Diane, Holbrook, Anne, Lamontagne, Francois, Walter, Stephen D., Ferguson, Niall D., Finfer, Simon, Arabi, Yaseen M., Bellomo, Rinaldo, Cooper, D. Jamie, Thabane, Lehana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616653/
https://www.ncbi.nlm.nih.gov/pubmed/26356708
http://dx.doi.org/10.1097/MD.0000000000001479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616653/
https://www.ncbi.nlm.nih.gov/pubmed/26356708
http://dx.doi.org/10.1097/MD.0000000000001479

Ejemplares similares